伤寒结合疫苗在卡拉奇郊区对培养确诊伤寒的有效性:病例对照研究
在巴基斯坦卡拉奇Lyari镇开展匹配病例对照研究,评估伤寒结合疫苗(TCV)对6月龄至15岁儿童培养确诊伤寒的保护效果。结果显示调整年龄和性别后疫苗有效性为72%(95%CI:34%-88%),单剂TCV在广泛耐药伤寒暴发社区中有效。
要点
- 单剂TCV对6月龄至15岁儿童培养确诊伤寒的调整疫苗有效性为72%(95%CI:34%-88%)。
核心结论
- 单剂TCV在巴基斯坦卡拉奇郊区广泛耐药伤寒暴发社区中,对6月龄至15岁儿童培养确诊伤寒具有保护效果。
研究设计与样本
- 在TCV大规模免疫接种后,于卡拉奇Lyari镇三家主要医院开展匹配病例对照研究。
- 纳入82例6月龄至15岁培养确诊伤寒病例,每例匹配至少1名年龄匹配的医院对照和2名年龄匹配的社区对照。
- 共纳入82名医院对照和164名社区对照,使用条件logistic回归计算调整比值比及95%CI。
主要发现
- 调整年龄和性别后的疫苗有效性为72%(95%CI:34%-88%)。
临床怎么用
- 在伤寒地方性流行或暴发社区,可为6月龄至15岁儿童接种单剂TCV以预防培养确诊伤寒。
- 评估伤寒风险时应关注频繁在外就餐等暴露因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enteric fever, caused by Salmonella Typhi and S. Paratyphi, is a cause of high morbidity and mortality among children in South Asia. Rising antimicrobial resistance presents an additional challenge. Typhoid Conjugate Vaccines (TCV) are recommended by the World Health Organization for use among people 6 months to 45 years old living in endemic settings. This study aimed to assess the effectiveness of TCV against culture-confirmed S. Typhi in Lyari Town, Karachi, Pakistan. This peri-urban town was one of the worst affected by the outbreak of extensively drug resistant (XDR) typhoid that started in November 2016. METHODS: A matched case-control study was conducted following a mass immunization campaign with TCV at three key hospitals in Lyari Town Karachi, Pakistan. Children aged 6 months to 15 years presenting with culture-confirmed S. Typhi were enrolled as cases. For each case, at least 1 age-matched hospital control and two age-matched community controls were enrolled. Adjusted odds ratios with 95% confidence intervals (CIs) were calculated using conditional logistic regression. RESULTS: Of 82 typhoid fever patients enrolled from August 2019 through December 2019, 8 (9·8%) had received vaccine for typhoid. Of the 164 community controls and 82 hospital controls enrolled, 38 (23·2%) community controls and 27 (32·9%) hospital controls were vaccinated for typhoid. The age and sex-adjusted vaccine effectiveness was found to be 72% (95% CI: 34% - 88%). The consumption of meals prepared outside home more than once per month (adjusted odds ratio: 3·72, 95% CI: 1·55- 8·94; p-value: 0·003) was associated with the development of culture-confirmed typhoid. CONCLUSION: A single dose of TCV is effective against culture confirmed typhoid among children aged 6 months to 15 years old in an XDR typhoid outbreak setting of a peri-urban community in Karachi, Pakistan.
引用
- Batool R, Tahir Yousafzai M, Qureshi S, et al. Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study. Vaccine. 2021. PMID: 34465474. doi:10.1016/j.vaccine.2021.08.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。